Eckert & Ziegler is a multinational organisation specialising in the handling and processing of isotope technology materials. These operations are conducted in purpose-built, accredited production facilities located in Europe, the United States, and Latin America. The company offers contract development and manufacturing services for radiopharmaceuticals and radioactive medical devices.

Among its key products is the 68Ge/68Ga radionuclide generator GalliaPharm, which facilitates the production of Gallium-68. This isotope is primarily utilised for the radiolabelling of carrier molecules, notably in PET imaging for the diagnosis of neuroendocrine tumours and prostate cancer.